About Proteros
Proteros is a company based in Martinsried (Germany) founded in 1999 by Robert Huber. Proteros has raised $13.2 million across 3 funding rounds from investors including Inflexion and BayBG. The company has 103 employees as of December 31, 2020. Proteros offers products and services including Drug Discovery Services, Structural Biology Services, Protein Science Services, Biologics Services, and Assays and Screening Services. Proteros operates in a competitive market with competitors including Nabla, Biomatter, Fina Biosolutions, Peak Proteins and Crelux, among others.
- Headquarter Martinsried, Germany
- Employees 103 as on 31 Dec, 2020
- Founders Robert Huber
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proteros Biostructures Gmbh
-
Annual Revenue
Not available
-
Net Profit
$4.85 M (USD)-1as on Sep 30, 2021
-
EBITDA
Not available
-
Total Equity Funding
$13.2 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Inflexion
& 1 more
-
Employee Count
103
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proteros
Proteros offers a comprehensive portfolio of products and services, including Drug Discovery Services, Structural Biology Services, Protein Science Services, Biologics Services, and Assays and Screening Services.
Delivers early stage drug discovery for challenging targets.
Provides X-Ray Crystallography and Cryo-EM for protein structures.
Offers protein preparation and functional analysis techniques.
Handles expression and characterization of complex biologics.
Develops biochemical and biophysical assays for screening.
Funding Insights of Proteros
Proteros has successfully raised a total of $13.2M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Proteros
Proteros has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Inflexion and BayBG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Inflexion is engaged in mid-market private equity investments across Europe.
|
Locked | Locked | Locked | |
|
Private equity investments are managed by BayBG in Germany.
|
Locked | Locked | Locked |
Investor details for Proteros
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proteros
Investment portfolio details for Proteros
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proteros
Detailed financials for Proteros
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proteros Comparisons
Peer comparison for Proteros
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proteros
Proteros operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nabla, Biomatter, Fina Biosolutions, Peak Proteins and Crelux, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Synthetic biology platform for functional protein identification is provided.
|
|
| Locked | Locked | Locked |
Provider of synthetic biology and AI-based technology for generative protein design
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Protein expression, purification, and structural biology services are provided.
|
|
| Locked | Locked | Locked |
X-ray crystallography and fragment-based drug discovery services are provided.
|
Detailed competitors of Proteros
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proteros
Complete news archive for Proteros
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proteros
Proteros was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Proteros is headquartered in Martinsried, Germany. It is registered at Martinsried, Bayern, Germany.
Proteros is a funded company, having raised a total of $13.2M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Proteros is 103.
Proteros was founded in 1999 and is headquartered in Martinsried, Germany. Drug discovery services are offered in the biotechnology sector, focusing on protein biochemistry, crystallography, biophysics, and medicinal chemistry. Operations include biochemical and biophysical profiling of protein-ligand interactions via proprietary assays, customized protein and antibody production, structural biology support, and lead discovery for kinase and GPCR inhibitors.
Proteros's top competitors include Nabla, Fina Biosolutions and Biomatter.
Proteros offers Drug Discovery Services, Structural Biology Services, Protein Science Services, Biologics Services, and Assays and Screening Services.